The role of m6A modification in physiology and disease
- PMID: 33162550
- PMCID: PMC7649148
- DOI: 10.1038/s41419-020-03143-z
The role of m6A modification in physiology and disease
Abstract
Similar to DNA epigenetic modifications, multiple reversible chemical modifications on RNAs have been uncovered in a new layer of epigenetic modification. N6-methyladenosine (m6A), a modification that occurs in ~30% transcripts, is dynamically regulated by writer complex (methylase) and eraser (RNA demethylase) proteins, and is recognized by reader (m6A-binding) proteins. The effects of m6A modification are reflected in the functional modulation of mRNA splicing, export, localization, translation, and stability by regulating RNA structure and interactions between RNA and RNA-binding proteins. This modulation is involved in a variety of physiological behaviors, including neurodevelopment, immunoregulation, and cellular differentiation. The disruption of m6A modulations impairs gene expression and cellular function and ultimately leads to diseases such as cancer, psychiatric disorders, and metabolic disease. This review focuses on the mechanisms and functions of m6A modification in a variety of physiological behaviors and diseases.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures


Similar articles
-
The RNA Modification N6-methyladenosine and Its Implications in Human Disease.Genomics Proteomics Bioinformatics. 2017 Jun;15(3):154-163. doi: 10.1016/j.gpb.2017.03.002. Epub 2017 May 19. Genomics Proteomics Bioinformatics. 2017. PMID: 28533023 Free PMC article. Review.
-
N6-methyladenosine modification in mRNA: machinery, function and implications for health and diseases.FEBS J. 2016 May;283(9):1607-30. doi: 10.1111/febs.13614. Epub 2015 Dec 31. FEBS J. 2016. PMID: 26645578 Review.
-
Reversible RNA Modification N1-methyladenosine (m1A) in mRNA and tRNA.Genomics Proteomics Bioinformatics. 2018 Jun;16(3):155-161. doi: 10.1016/j.gpb.2018.03.003. Epub 2018 Jun 14. Genomics Proteomics Bioinformatics. 2018. PMID: 29908293 Free PMC article. Review.
-
N6-Methyladenosine RNA Modification in Normal and Malignant Hematopoiesis.Adv Exp Med Biol. 2023;1442:105-123. doi: 10.1007/978-981-99-7471-9_7. Adv Exp Med Biol. 2023. PMID: 38228961
-
m6A RNA Modification Determines Cell Fate by Regulating mRNA Degradation.Cell Reprogram. 2017 Aug;19(4):225-231. doi: 10.1089/cell.2016.0041. Epub 2017 Jul 6. Cell Reprogram. 2017. PMID: 28682669 Review.
Cited by
-
The Roles of N6-Methyladenosine Modification in Plant-RNA Virus Interactions.Int J Mol Sci. 2023 Oct 26;24(21):15608. doi: 10.3390/ijms242115608. Int J Mol Sci. 2023. PMID: 37958594 Free PMC article. Review.
-
WTAP-mediated m6A modification of FRZB triggers the inflammatory response via the Wnt signaling pathway in osteoarthritis.Exp Mol Med. 2024 Feb;56(1):156-167. doi: 10.1038/s12276-023-01135-5. Epub 2024 Jan 4. Exp Mol Med. 2024. PMID: 38172596 Free PMC article.
-
The Emerging Role of N6-Methyladenosine RNA Methylation as Regulators in Cancer Therapy and Drug Resistance.Front Pharmacol. 2022 Apr 6;13:873030. doi: 10.3389/fphar.2022.873030. eCollection 2022. Front Pharmacol. 2022. PMID: 35462896 Free PMC article. Review.
-
Intermittent Fasting Improves High-Fat Diet-Induced Obesity Cardiomyopathy via Alleviating Lipid Deposition and Apoptosis and Decreasing m6A Methylation in the Heart.Nutrients. 2022 Jan 7;14(2):251. doi: 10.3390/nu14020251. Nutrients. 2022. PMID: 35057432 Free PMC article.
-
Klf6 aggravates myocardial ischemia/reperfusion injury by activating Acsl4-mediated ferroptosis.Kaohsiung J Med Sci. 2023 Oct;39(10):989-1001. doi: 10.1002/kjm2.12733. Epub 2023 Aug 2. Kaohsiung J Med Sci. 2023. PMID: 37530646 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical